Jazz Pharmaceuticals Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary Marketline’s Jazz Pharmaceuticals Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Jazz Pharmaceuticals Plc since January2007.
Synopsis Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.
Key Highlights This report includes Jazz Pharmaceuticals Plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Jazz Pharmaceuticals Plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.
Scope - Provides intelligence on Jazz Pharmaceuticals Plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions. - Detailed reports of various financial transactions undertaken by Jazz Pharmaceuticals Plc and its subsidiaries since 2007. - Information about key financial and legal advisors for Jazz Pharmaceuticals Plc’s financial deals transactions. - Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.
Reasons to buy - Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances. - Form an independent opinion about Jazz Pharmaceuticals Plc’s growth strategies through the organic and inorganic activities undertaken since 2007. - Track your competitors’ business structure and growth strategies.
Our reports have been used by over 10K customers, including:
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
This IDC Perspective provides IDC Health Insights' overview of key IT deals, news, and digital initiatives in the European life sciences and pharma industries in Q1 2021. In the evolving COVID-19 scenario, it is critical for European life sciences companies and their technology suppliers to closely follow the fast-moving trends and developments...
What’s Ahead for the Pharmaceutical Industry?--Emerging Opportunities and Growth Strategies for Suppliers The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure, the assessments include all or some of the following analyses: Organization...
249 pages •
By Asia Market Information & Development Company
• May 2021
China’s demand for Therapy has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...
120 pages •
By Infiniti Research Limited
• May 2021
Global Microbiomes Market 2021-2025 The analyst has been monitoring the microbiomes market and it is poised to grow by $ 713.01 million during 2021-2025, progressing at a CAGR of over 24% during the forecast period. Our report on microbiomes market provides a holistic analysis, market size and forecast, trends, growth drivers,...
The Alzheimer’s disease diagnostics and therapeutics market was valued at USD 6,632.82 million in 2020, and it is expected to reach approximately USD 9,073 million in 2026, registering a CAGR of nearly 5.36% during the forecast period, 2021-2026. The study titled, "Alzheimer’s and Parkinson’s diseases predict different COVID-19 outcomes, a...
547 pages •
By Global Industry Analysts
• Apr 2021
- The global market for Refined Glycerin is forecast to reach 8.1 billion pounds by 2022, driven by the growing preference for renewable feedstocks as against petroleum derived feedstocks and fairly encouraging business climate in all major end-use application sectors like food and pharma which continue to grow...